Beactica Therapeutics is a specialist drug discovery and development company, committed to the fight against cancer. Beactica is advancing a proprietary pipeline of first-in-class therapeutics by applying its molecular interaction-based drug discovery engine synergistically across multiple small molecule modalities – including allosteric modulators, protein–protein interaction inhibitors and targeted protein degraders (PROTACs).
View Top Employees from Beactica Therapeutics| Website | http://www.beactica.com |
| Revenue | $6 million |
| Employees | 18 (12 on RocketReach) |
| Founded | 2006 |
| Address | 2 Virdings Allé, Uppsala, Uppsala 754 50, SE |
| Phone | (461) 856-0880 |
| Industry | Pharmaceutical Manufacturing, Business Services General, Health Care, Surface Plasmon Resonance (SPR), Business Services, Medical, Fragment-Based Drug Discovery, Interaction Analysis, Drug Design, Lead generation, Kinetics, Mechanism of action, Epigenetics, Oncology, Kinase inhibitors |
| Web Rank | 18 Million |
| Keywords | To Present Poster At Aacr Press Release |
| Competitors | Biacore, Bioleap, Inc., De Novo Pharmaceuticals, Provid Pharmaceuticals, SEEK Group (PepTcell Limited) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies |
Looking for a particular Beactica Therapeutics employee's phone or email?
Beactica Therapeutics Questions
The Beactica Therapeutics annual revenue was $6 million in 2024.
Johan Winquist is the Head Of Operations of Beactica Therapeutics.
12 people are employed at Beactica Therapeutics.
Beactica Therapeutics is based in Uppsala, Uppsala.
The NAICS codes for Beactica Therapeutics are [54, 54171, 541, 5417, 541714].
The SIC codes for Beactica Therapeutics are [873, 87].
Top Beactica Therapeutics Employees
-
2
-
2
-
3
-
2
Related Companies
